Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-09-17
1994-02-01
Bernhardt, Emily
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514253, 544376, 544398, 544399, 544401, A61K 31495, C07D295088, C07D295092, C07D40506
Patent
active
052832465
ABSTRACT:
The compounds are substituted trimetazidine useful for the treatment of ischaemic pathologies and peripheral vascular pathology.
A compound disclosed is 4-(2,3,4-trimethoxybenzyl)-1-[3-(4-hydroxy-2,3,5-trimethylphenoxy)propyl]p iperazine.
REFERENCES:
patent: 4100285 (1978-07-01), Murai et al.
patent: 4728650 (1988-03-01), Eziri et al.
Erizi et al., Chemical Abstracts, vol. 109, No. 22844 (1988) (Abstract for WO 87 05020, Aug. 27, 1987).
Bidouard Jean-Pierre
Iliou Jean-Pierre
Lenaers Albert
Regnier Gilbert
Vilaine Jean-Paul
Adir et Compagnie
Bernhardt Emily
Hueschen Gordon W.
LandOfFree
Trimetazidine compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Trimetazidine compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Trimetazidine compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-579991